China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · Real-Time Price · USD

2.330

-0.330 (-12.41%)

Sep 15, 2026, 3:10 PM EDT - Market open

China SXT Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	3	1	34	1	3	-
Market Cap Growth	-98.66%	-95.82%	4154.69%	-70.38%	-	-
Enterprise Value	-24	-19	26	-8	1	-
Last Close Price	2.66	134.40	29938.63	161279.48	680585.55	13461538.46

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PS Ratio	3.09	1.26	19.71	0.42	1.38	-
PB Ratio	0.00	0.05	2.22	0.06	0.19	-
P/TBV Ratio	0.12	0.05	2.22	0.06	0.19	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	-	-	14.75	-	0.67	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.04	0.04	0.06	0.27	0.61	0.65
Debt / FCF Ratio	-	-	-	-	-	52.20
Net Debt / Equity Ratio	-0.92	-0.92	-1.12	-0.60	-0.57	-0.29
Net Debt / EBITDA Ratio	3.86	3.86	6.64	4.43	1.68	0.98
Net Debt / FCF Ratio	6.77	6.77	7.35	4.33	55.52	-23.24
Asset Turnover	0.04	0.04	0.08	0.07	0.06	0.08
Inventory Turnover	0.44	0.44	1.42	1.98	1.88	1.10
Quick Ratio	7.23	7.23	3.33	1.51	1.31	1.14
Current Ratio	7.94	7.94	3.54	1.60	1.35	1.31
Return on Equity (ROE)	-27.49%	-27.49%	-22.50%	-21.65%	-38.15%	-35.42%
Return on Assets (ROA)	-15.78%	-15.78%	-7.48%	-4.96%	-10.42%	-9.53%
Return on Invested Capital (ROIC)	-284.06%	-2051.57%	-143.27%	-35.35%	-58.67%	-39.22%
Return on Capital Employed (ROCE)	-23.40%	-23.40%	-17.10%	-14.70%	-34.90%	-31.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Earnings Yield	-176.53%	-432.74%	-9.63%	-384.24%	-218.00%	-
FCF Yield	-114.30%	-280.17%	-6.84%	-239.97%	-5.56%	-
Buyback Yield / Dilution	-	-	-	-	-	86.91%

SEC Filings: 10-K · 10-Q